Menu
GeneBe

13-102687013-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001010977.3(METTL21C):ā€‹c.327G>Cā€‹(p.Leu109Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000377 in 1,614,164 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00055 ( 1 hom., cov: 33)
Exomes š‘“: 0.00036 ( 0 hom. )

Consequence

METTL21C
NM_001010977.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.41
Variant links:
Genes affected
METTL21C (HGNC:33717): (methyltransferase 21C, AARS1 lysine) Enables heat shock protein binding activity and protein-lysine N-methyltransferase activity. Involved in protein methylation. Located in nucleus. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0041956306).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
METTL21CNM_001010977.3 linkuse as main transcriptc.327G>C p.Leu109Phe missense_variant 3/4 ENST00000267273.7
METTL21CXM_047430117.1 linkuse as main transcriptc.327G>C p.Leu109Phe missense_variant 5/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
METTL21CENST00000267273.7 linkuse as main transcriptc.327G>C p.Leu109Phe missense_variant 3/41 NM_001010977.3 P1

Frequencies

GnomAD3 genomes
AF:
0.000552
AC:
84
AN:
152212
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00779
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000469
AC:
118
AN:
251430
Hom.:
1
AF XY:
0.000523
AC XY:
71
AN XY:
135884
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00536
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000404
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000359
AC:
525
AN:
1461834
Hom.:
0
Cov.:
30
AF XY:
0.000364
AC XY:
265
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000402
Gnomad4 ASJ exome
AF:
0.00509
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000104
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000301
Gnomad4 OTH exome
AF:
0.000414
GnomAD4 genome
AF:
0.000551
AC:
84
AN:
152330
Hom.:
1
Cov.:
33
AF XY:
0.000591
AC XY:
44
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.0000962
Gnomad4 AMR
AF:
0.00163
Gnomad4 ASJ
AF:
0.00779
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000828
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000323
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.000880
Hom.:
0
Bravo
AF:
0.000612
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000428
AC:
52
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000356

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 02, 2021The c.327G>C (p.L109F) alteration is located in exon 3 (coding exon 3) of the METTL21C gene. This alteration results from a G to C substitution at nucleotide position 327, causing the leucine (L) at amino acid position 109 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
10
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0022
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.0073
T
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.57
N
MutationTaster
Benign
0.66
N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.080
N
REVEL
Benign
0.023
Sift
Benign
0.27
T
Sift4G
Benign
0.33
T
Polyphen
0.071
B
Vest4
0.051
MutPred
0.47
Loss of disorder (P = 0.1774);
MVP
0.26
MPC
0.22
ClinPred
0.042
T
GERP RS
2.1
Varity_R
0.15
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148307139; hg19: chr13-103339363; API